Inactive Instrument

Other languages Vyant Bio, Inc.

Equities

VYNT

US92942V2088

Other languages

Unlock all the news: Be the first to know and act before the market!

Vyant Bio, Inc. Estimates Liquidation Payments to its Shareholders	Nov. 10
Vyant Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16
Vyant Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-31
Top Midday Decliners	23-04-25
Vyant Bio to Voluntarily Delist From Nasdaq, Deregister From SEC; Shares Slide After Hours	23-04-24
Vyant Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Vyant Bio, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
Vyant Bio CEO to Step Down, Successor Named; Cuts Staff as Strategic Review Process Gets Underway	23-02-03
Vyant Bio, Inc. Announces Executive Changes	23-02-03
Vyant Bio, Inc. Announces CEO Changes	23-02-03
Strong Labor Data in Spotlight After Hawkish Fed Minutes, US Equity Futures Turned Lower Ahead of Opening Bell	23-01-05
Top Premarket Gainers	23-01-05
Vyant Bio Taps LifeSci Capital to Assist in Review of Strategic Options	23-01-05
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives	23-01-03
Top Premarket Decliners	22-12-29
Vyant Bio, Inc. Terminates the Employment Contract of Ralf Brandt, Ph.D. Effective December 31, 2022	22-12-05
Vyant Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Vyant Bio, Inc. to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16, 2022	22-11-10
Reaction Biology Corporation acquired vivoPharm, LLC from Vyant Bio, Inc. for approximately $6 million.	22-11-02
Earnings Flash (VYNT) VYANT BIO Posts Q2 Revenue $165,000, vs. Street Est of $0.2M	22-08-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vyant Bio, Inc.

Equities

VYNT

US92942V2088

Other languages

Filters